Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - March 2011

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for March 2011 (PDF).

This issue contains drug safety information advising that modafinil (Provigil®) is now exclusively indicated for the treatment of excessive sleepiness in adults with narcolepsy, with or without cataplexy. It is no longer indicated for shift-worker sleep disorder and obstructive sleep apnoea. Patients with these conditions are advised to see their doctor.

Additional information is provided to promote safer use including avoiding use in those with uncontrolled hypertension or cardiac arrhythmias, children up to 18 years old and women who are pregnant or breast feeding. It is also recommended that a baseline ECG is performed before starting treatment and that blood pressure and pulse rate are monitored during treatment.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - March 2011' on Email Share 'Drug Safety Update - March 2011' on Delicious Share 'Drug Safety Update - March 2011' on Digg Share 'Drug Safety Update - March 2011' on Facebook Share 'Drug Safety Update - March 2011' on Google+ Share 'Drug Safety Update - March 2011' on reddit Share 'Drug Safety Update - March 2011' on StumbleUpon Share 'Drug Safety Update - March 2011' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - March 2011”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,512 spam comments.

atomic-wealth
fond-illness
summer